Yixintang Pharmaceutical Group Co (SZSE:002727) LT-Debt-to-Total-Asset : 0.09 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Yixintang Pharmaceutical Group Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Yixintang Pharmaceutical Group Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.09.

Yixintang Pharmaceutical Group Co's long-term debt to total assets ratio declined from Mar. 2023 (0.12) to Mar. 2024 (0.09). It may suggest that Yixintang Pharmaceutical Group Co is progressively becoming less dependent on debt to grow their business.

Yixintang Pharmaceutical Group Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Yixintang Pharmaceutical Group Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yixintang Pharmaceutical Group Co LT-Debt-to-Total-Asset Chart

Yixintang Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.06

0.15

0.12

0.11

0.09

Yixintang Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.12	0.12	0.11	0.09	0.09

Yixintang Pharmaceutical Group Co LT-Debt-to-Total-Asset Calculation

Yixintang Pharmaceutical Group Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	1552.17	/	16647.375
	=	0.09

Yixintang Pharmaceutical Group Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	1626.601	/	17540.628
	=	0.09

Yixintang Pharmaceutical Group Co (SZSE:002727) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Yixintang Pharmaceutical Group Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Yixintang Pharmaceutical Group Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Yixintang Pharmaceutical Group Co (SZSE:002727) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yixintang Pharmaceutical Group Co Ltd (SZSE:002727) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

No. 1 Hongxiang Road, Economic Development Zone, Yunnan province, Kunming City, CHN, 650500

Website

http://www.hx8886.com

Yixintang Pharmaceutical Group Co Ltd is a China-based company engages in the operation of pharmaceutical retail chains and wholesale businesses. Its products include traditional Chinese medicine, Western medicine, and medical equipment.

Executives

Zhang Yong	Directors, executives
Xiao Dong Lei	Executives
Liu Qiong	Director
Ruan Hong Xian	Directors, executives
Guo Chun Li	Director
Ruan Guo Wei	Directors, executives
Li Zheng Hong	Directors, executives
Zhao Biao	Directors, executives
Tian Jun	Directors, Directors, and Executives
Xu Ke Yi	Director
Luo Yong Bin	Executives
Zhou Hong Yun	Directors, executives

Yixintang Pharmaceutical Group Co (SZSE:002727) Headlines

No Headlines